CARR vs SPRY · P/E 43, rev $5.15B vs rev $89.1M
Carrier Global Corp (CARR) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported CARR revenue for 2024-12-31 was $5.15B. Net income was $5.71B. Revenue was down 14.0% from 2024-09-30 to 2024-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the CARR and SPRY stock pages for the full models.
Not investment advice.